Federation Des Caisses Desjardins Du Quebec Supernus Pharmaceuticals, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Aug 30, 2024	SELL	$42.7 - $56.55 $58,584 - $77,586	-1,372 Reduced 57.84%	1,000 $50.4 Million
Q2 2018 Aug 30, 2024	SELL	$44.1 - $59.85 $675,038 - $916,123	-15,307 Reduced 86.58%	2,372 $142 Million
Q1 2018 Aug 30, 2024	SELL	$37.15 - $46.9 $434,877 - $549,011	-11,706 Reduced 39.84%	17,679 $810 Million
Q4 2017 Aug 30, 2024	SELL	$36.4 - $42.6 $87,869 - $102,836	-2,414 Reduced 7.59%	29,385 $1.17 Billion
Q3 2017 Aug 30, 2024	SELL	$36.75 - $49.65 $25,725 - $34,755	-700 Reduced 2.15%	31,799 $1.27 Billion
Q2 2017 Aug 30, 2024	BUY	N/A	1,650 Added 5.35%	32,499 $1.4 Billion
Q1 2017 Aug 30, 2024	BUY	N/A	30,849	30,849 $966 Million

Others Institutions Holding SUPN

# of Institutions

283

Shares Held

60.6M

Call Options Held

27.7K

Put Options Held

11.3K

Black Rock Inc. New York, NY

10.4M
Shares

$410 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

6.13M
Shares

$242 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.1M
Shares

$201 Million
2.64% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.88M
Shares

$114 Million
0.02% of portfolio
Macquarie Group LTD Australia, C3

2.63M
Shares

$104 Million
0.09% of portfolio

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.11B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account